Oncology Clinical Trials in Durham, NC

As of September 2026, 206 paid clinical trials are recruiting for Oncology in Durham, North Carolina. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

206 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Durham, NC.

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

for Newly Diagnosed Glioblastoma

1 location in Durham

Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP

Sex: All·Age: 18+

Code: NCT04903795·Phase 1·Recruiting·Listed May 2021

Apply to this trial

Planning Grant for TOPS for Breast Cancer Survivors

for Breast Cancer

1 location in Durham

Sponsor: Duke University

Sex: Female·Age: 21 - 90

Code: NCT06658912·Recruiting·Listed Oct 2024

Apply to this trial

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for Solid Tumor

Sites in Durham +15 more locations

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT06874335·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

for Hematologic Malignancy

1 location in Durham

Sponsor: Duke University

Sex: All·Age: 18+

Code: NCT06532773·Recruiting·Listed Aug 2024

Apply to this trial

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

for Head and Neck Squamous Cell Carcinoma

Drug: Petosemtamab

Sites in Durham, Winston-Salem +34 more locations

Sponsor: Merus B.V.

Sex: All·Age: 18+

Code: NCT06525220·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

for Solid Tumor

Sites in Durham +6 more locations

Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female·Age: 18+

Code: NCT04516447·Phase 1·Recruiting·Listed Aug 2020

Apply to this trial

Conditions in Oncology (Durham, NC)

Solid tumor· 35 Breast cancer· 24 Prostate cancer· 20 Cancer (any)· 20 Non-small cell lung cancer (NSCLC)· 15 Colorectal cancer· 15 Pancreatic cancer· 12 Ovarian cancer· 11 Acute myeloid leukemia (AML)· 11 Multiple myeloma· 9 Metastatic prostate cancer· 8 Endometrial cancer· 8 Glioblastoma· 8 Chronic lymphocytic leukemia (CLL)· 8 Non-Hodgkin lymphoma· 8 Hematologic malignancy· 8 Head and neck cancer· 8 Metastatic breast cancer· 7 Glioma· 7 Melanoma· 6 Lung cancer· 5 Bladder cancer· 5 Myelodysplastic syndromes (MDS)· 5 Myelofibrosis· 5 Mantle cell lymphoma· 5 Triple-negative breast cancer· 4 Esophageal cancer· 4 Cervical cancer· 4 Follicular lymphoma· 4 Sarcoma· 4 Neuroblastoma· 4 HER2-negative breast cancer· 3 Liver cancer· 3 Kidney cancer· 3 Acute lymphoblastic leukemia· 3 Leukemia (other)· 3 Diffuse large B-cell lymphoma (DLBCL)· 3 Small lymphocytic lymphoma· 3 Osteosarcoma· 3 HER2-positive breast cancer· 2 Small cell lung cancer· 2 Gastric cancer· 2 Biliary tract cancer· 2 Fallopian tube cancer· 2 Chronic myelomonocytic leukemia· 2 Marginal zone lymphoma· 2 Thyroid cancer· 2 Metastatic colorectal cancer· 1 Colon cancer· 1 Gastroesophageal junction cancer· 1 Gastrointestinal cancer· 1 Uterine cancer· 1 Gynecologic cancer· 1 Brain metastases· 1 Myeloproliferative neoplasm· 1 Hodgkin lymphoma· 1 Burkitt lymphoma· 1 Soft tissue sarcoma· 1 Mesothelioma· 1